Literature DB >> 20221875

The role of paraoxonase 1 in the detoxification of homocysteine thiolactone.

Hieronim Jakubowski1.   

Abstract

The thioester homocysteine (Hcy)-thiolactone, product of an error-editing reaction in protein biosynthesis, forms when Hcy is mistakenly selected by methionyl-tRNA synthetase. Accumulating evidence suggests that Hcy-thiolactone plays an important role in atherothrombosis. The thioester chemistry of Hcy-thiolactone underlies its ability to form isopeptide bonds with protein lysine residues, which impairs or alters protein function and has pathophysiological consequences including activation of an autoimmune response and enhanced thrombosis. Mammalian organisms, including human, have evolved the ability to eliminate Hcy-thiolactone. One such mechanism involves paraoxonase 1 (PON1), which has the ability to hydrolyze Hcy-thiolactone. This article outlines Hcy-thiolactone pathobiology and reviews evidence documenting the role of PON1 in minimizing Hcy-thiolactone and N-Hcy-protein accumulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20221875     DOI: 10.1007/978-1-60761-350-3_11

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  21 in total

1.  Metabolism and neurotoxicity of homocysteine thiolactone in mice: evidence for a protective role of paraoxonase 1.

Authors:  Kamila Borowczyk; Diana M Shih; Hieronim Jakubowski
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Effect of homocysteine thiolactone on structure and aggregation propensity of bovine pancreatic insulin.

Authors:  Shima Jalili; Reza Yousefi; Mohammad-Mehdi Papari; Ali Akbar Moosavi-Movahedi
Journal:  Protein J       Date:  2011-06       Impact factor: 2.371

3.  Effect of Hyperhomocysteinemia on Redox Balance and Redox Defence Enzymes in Ischemia-Reperfusion Injury and/or After Ischemic Preconditioning in Rats.

Authors:  Martin Petráš; Anna Drgová; Mária Kovalská; Zuzana Tatarková; Barbara Tóthová; Oľga Križanová; Ján Lehotský
Journal:  Cell Mol Neurobiol       Date:  2017-02-16       Impact factor: 5.046

Review 4.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

5.  Daily supplementation with fresh pomegranate juice increases paraoxonase 1 expression and activity in mice fed a high-fat diet.

Authors:  D Estrada-Luna; E Martínez-Hinojosa; J C Cancino-Diaz; H Belefant-Miller; G López-Rodríguez; G Betanzos-Cabrera
Journal:  Eur J Nutr       Date:  2017-02-27       Impact factor: 5.614

6.  Evidence for the presence of active paraoxonase 1 in small-dense low-density lipoprotein.

Authors:  Alejandro Gugliucci; Russell Caccavello; Kazuhiko Kotani; Satoshi Kimura
Journal:  Redox Rep       Date:  2014-02-14       Impact factor: 4.412

7.  Role of paraoxonase-1 in the protection of hydrogen sulfide-donating sildenafil (ACS6) against homocysteine-induced neurotoxicity.

Authors:  Xiao-Qing Tang; Rong-Qian Chen; Ling Dong; Yan-Kai Ren; Piero Del Soldato; Anna Sparatore; Duan-Fang Liao
Journal:  J Mol Neurosci       Date:  2012-07-29       Impact factor: 3.444

Review 8.  Paraoxonase 1 in neurological disorders.

Authors:  Teresita Menini; Alejandro Gugliucci
Journal:  Redox Rep       Date:  2013-11-12       Impact factor: 4.412

Review 9.  Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis.

Authors:  Ayman Samir Farid; Yoichiro Horii
Journal:  Lipids Health Dis       Date:  2012-07-23       Impact factor: 3.876

10.  Expression of human paraoxonase 1 decreases superoxide levels and alters bacterial colonization in the gut of Drosophila melanogaster.

Authors:  Alejandro A Pezzulo; Emma E Hornick; Michael V Rector; Miriam Estin; Anna C Reisetter; Peter J Taft; Stephen C Butcher; A Brent Carter; J Robert Manak; David A Stoltz; Joseph Zabner
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.